Group 1 - The stock of Kangtong Medical (301515) closed at 21.23 yuan on January 7, 2026, down 3.85%, with a turnover rate of 8.43% and a trading volume of 55,300 hands, resulting in a transaction amount of 119 million yuan [1] - On January 7, the net outflow of main funds was 12.1 million yuan, accounting for 10.2% of the total transaction amount, while retail funds saw a net inflow of 2.8 million yuan, representing 2.36% of the total transaction amount [1] - The financing data for Kangtong Medical shows a financing buy of 10.94 million yuan and a financing repayment of 14.57 million yuan, resulting in a net repayment of 3.62 million yuan [2] Group 2 - For the first three quarters of 2025, Kangtong Medical reported a main revenue of 344 million yuan, a year-on-year decrease of 30.06%, and a net profit attributable to shareholders of -10.21 million yuan, down 150.92% [3] - In Q3 2025, the company achieved a single-quarter main revenue of 79.12 million yuan, an increase of 42.81% year-on-year, but the net profit attributable to shareholders was -1.80 million yuan, a decline of 138.94% [3] - The company's debt ratio stands at 40.94%, with an investment income of -179,400 yuan and financial expenses of 542,400 yuan, while the gross profit margin is 22.45% [3]
港通医疗（301515）1月7日主力资金净卖出1209.55万元